Impulse Control Disorders in Parkinson's Disease: Epidemiology, Pathogenesis and Therapeutic Strategies

Overview

Journal Front Psychiatry

Specialty Psychiatry

Date 2021 Feb 26

PMID 33633615

Citations 13

Authors

Jun-Fang Zhang

Xi-Xi Wang

Ya Feng

Robert Fekete

Joseph Jankovic

Yun-Cheng Wu

Affiliations

Soon will be listed here.

Abstract

Impulse control disorders (ICDs) in Parkinson's disease (PD) are aberrant behavior such as pathological gambling, hypersexuality, binge eating, and compulsive buying, which typically occur as a result of dopaminergic therapy. Numerous studies have focused on the broad spectrum of ICDs-related behaviors and their tremendous impact on patients and their family members. Recent advances have improved our understanding of ICDs. In this review, we discuss the epidemiology, pathogenesis and treatment of ICDs in the setting of PD.

Citing Articles

Impulse control disorders in Parkinson's disease: What's new?.

Marques A, Lewis S J Neurol. 2025; 272(2):138.

PMID: 39812828 DOI: 10.1007/s00415-024-12865-5.

APOE contributes to longitudinal impulse control disorders progression in Parkinson's disease.

Chen L, He X, Mao L, Liu P BMC Psychiatry. 2024; 24(1):632.

PMID: 39334114 PMC: 11438395. DOI: 10.1186/s12888-024-06084-5.

Palmatine Ameliorates Motor Deficits and Dopaminergic Neuron Loss by Regulating NLRP3 Inflammasome through Mitophagy in Parkinson's Disease Model Mice.

Zhao J, Wang J, Zhao K, Yang S, Dong J, Zhang Y Mol Neurobiol. 2024; 62(2):2250-2263.

PMID: 39096445 PMC: 11772544. DOI: 10.1007/s12035-024-04367-2.

Rats Lacking the Dopamine Transporter Display Inflexibility in Innate and Learned Behavior.

Belskaya A, Kurzina N, Savchenko A, Sukhanov I, Gromova A, Gainetdinov R Biomedicines. 2024; 12(6).

PMID: 38927477 PMC: 11200708. DOI: 10.3390/biomedicines12061270.

Impulse Control Disorders in Parkinson's Disease and Atypical Parkinsonian Syndromes-Is There a Difference?.

Tos M, Grazynska A, Antoniuk S, Siuda J Brain Sci. 2024; 14(2).

PMID: 38391755 PMC: 10886884. DOI: 10.3390/brainsci14020181.

References

Goudriaan A, Yucel M, van Holst R . Getting a grip on problem gambling: what can neuroscience tell us?. Front Behav Neurosci. 2014; 8:141. PMC: 4033022. DOI: 10.3389/fnbeh.2014.00141. View

Morgante F, Fasano A, Ginevrino M, Petrucci S, Ricciardi L, Bove F . Impulsive-compulsive behaviors in parkin-associated Parkinson disease. Neurology. 2016; 87(14):1436-1441. PMC: 5075971. DOI: 10.1212/WNL.0000000000003177. View

Rolls E . The orbitofrontal cortex and reward. Cereb Cortex. 2000; 10(3):284-94. DOI: 10.1093/cercor/10.3.284. View

Ardouin C, Voon V, Worbe Y, Abouazar N, Czernecki V, Hosseini H . Pathological gambling in Parkinson's disease improves on chronic subthalamic nucleus stimulation. Mov Disord. 2006; 21(11):1941-6. DOI: 10.1002/mds.21098. View

Antonini A, Chaudhuri K, Boroojerdi B, Asgharnejad M, Bauer L, Grieger F . Impulse control disorder related behaviours during long-term rotigotine treatment: a post hoc analysis. Eur J Neurol. 2016; 23(10):1556-65. PMC: 5096013. DOI: 10.1111/ene.13078. View

Smith K, Xie S, Weintraub D . Incident impulse control disorder symptoms and dopamine transporter imaging in Parkinson disease. J Neurol Neurosurg Psychiatry. 2015; 87(8):864-70. PMC: 4854795. DOI: 10.1136/jnnp-2015-311827. View

Nirenberg M, Waters C . Compulsive eating and weight gain related to dopamine agonist use. Mov Disord. 2005; 21(4):524-9. DOI: 10.1002/mds.20757. View

Weintraub D, Sohr M, Potenza M, Siderowf A, Stacy M, Voon V . Amantadine use associated with impulse control disorders in Parkinson disease in cross-sectional study. Ann Neurol. 2010; 68(6):963-8. DOI: 10.1002/ana.22164. View

de Lau L, Breteler M . Epidemiology of Parkinson's disease. Lancet Neurol. 2006; 5(6):525-35. DOI: 10.1016/S1474-4422(06)70471-9. View

10.

Catalan M, De Pablo-Fernandez E, Villanueva C, Fernandez-Diez S, Lapena-Montero T, Garcia-Ramos R . Levodopa infusion improves impulsivity and dopamine dysregulation syndrome in Parkinson's disease. Mov Disord. 2013; 28(14):2007-10. DOI: 10.1002/mds.25636. View

11.

Biundo R, Weis L, Facchini S, Formento-Dojot P, Vallelunga A, Pilleri M . Patterns of cortical thickness associated with impulse control disorders in Parkinson's disease. Mov Disord. 2015; 30(5):688-95. DOI: 10.1002/mds.26154. View

12.

Munro C, McCaul M, Wong D, Oswald L, Zhou Y, Brasic J . Sex differences in striatal dopamine release in healthy adults. Biol Psychiatry. 2006; 59(10):966-74. DOI: 10.1016/j.biopsych.2006.01.008. View

13.

Vela L, Martinez Castrillo J, Garcia Ruiz P, Gasca-Salas C, Macias Macias Y, Perez Fernandez E . The high prevalence of impulse control behaviors in patients with early-onset Parkinson's disease: A cross-sectional multicenter study. J Neurol Sci. 2016; 368:150-4. DOI: 10.1016/j.jns.2016.07.003. View

14.

van Eimeren T, Pellecchia G, Cilia R, Ballanger B, Steeves T, Houle S . Drug-induced deactivation of inhibitory networks predicts pathological gambling in PD. Neurology. 2010; 75(19):1711-6. PMC: 3033606. DOI: 10.1212/WNL.0b013e3181fc27fa. View

15.

Weintraub D, Claassen D . Impulse Control and Related Disorders in Parkinson's Disease. Int Rev Neurobiol. 2017; 133:679-717. DOI: 10.1016/bs.irn.2017.04.006. View

16.

Gomez C, Duenas M, Bernal O, Araoz N, Saenz Farret M, Aldinio V . A Multicenter Comparative Study of Impulse Control Disorder in Latin American Patients With Parkinson Disease. Clin Neuropharmacol. 2017; 40(2):51-55. DOI: 10.1097/WNF.0000000000000202. View

17.

Knobel D, Aybek S, Pollo C, Vingerhoets F, Berney A . Rapid resolution of dopamine dysregulation syndrome (DDS) after subthalamic DBS for Parkinson disease (PD): a case report. Cogn Behav Neurol. 2008; 21(3):187-9. DOI: 10.1097/WNN.0b013e318185e6e2. View

18.

Antonini A, Barone P, Bonuccelli U, Annoni K, Asgharnejad M, Stanzione P . ICARUS study: prevalence and clinical features of impulse control disorders in Parkinson's disease. J Neurol Neurosurg Psychiatry. 2017; 88(4):317-324. DOI: 10.1136/jnnp-2016-315277. View

19.

Pontone G, Williams J, Bassett S, Marsh L . Clinical features associated with impulse control disorders in Parkinson disease. Neurology. 2006; 67(7):1258-61. DOI: 10.1212/01.wnl.0000238401.76928.45. View

20.

Comings D, Gonzalez N, Wu S, Gade R, Muhleman D, SAUCIER G . Studies of the 48 bp repeat polymorphism of the DRD4 gene in impulsive, compulsive, addictive behaviors: Tourette syndrome, ADHD, pathological gambling, and substance abuse. Am J Med Genet. 1999; 88(4):358-68. DOI: 10.1002/(sici)1096-8628(19990820)88:4<358::aid-ajmg13>3.0.co;2-g. View